BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Topics » Briefs » Regulatory actions

Regulatory actions
Regulatory actions RSS Feed RSS

Regulatory actions for Dec. 17, 2025

Dec. 17, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Celltivity, Clarius Mobile Health, CMR Surgial, Hyperfine, Medibeacon, Numares, Pathmaker Neurosystems, Rivanna Medical, Sleepres.
Read More

Regulatory actions for Dec. 16, 2025

Dec. 16, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abpro, Algia, Amphastar, Anavex, Biocryst, Celltrion, Fibrogen, Fortress, Innoviva, Janssen, Lenz, Leo, LIB, Milestone, Moderna, Pilatus, Sanofi, Vanda.
Read More

Regulatory actions for Dec. 16, 2025

Dec. 16, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BD, Bluewind Medical, May Health, Medivis, MPM Medical, Roche, Zephyrus.
Read More

Regulatory actions for Dec. 15, 2025

Dec. 15, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Apellis, Bio-Thera, GSK, Immunitybio, Kymera, Merck, Novo Nordisk, Sobi, Stada.
Read More

Regulatory actions for Dec. 15, 2025

Dec. 15, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Companion Spine, Hyperfine.
Read More

Regulatory actions for Dec. 12, 2025

Dec. 12, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Atossa, BMS, Innocare, Kymera, Praxis, Sanofi, Serina.
Read More

Regulatory actions for Dec. 12, 2025

Dec. 12, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Peijia Medical, Ruthless Spine, Zenflow.
Read More

Regulatory actions for Dec. 11, 2025

Dec. 11, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flow Neuroscience, Vesalio.
Read More

Regulatory actions for Dec. 10, 2025

Dec. 10, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Askbio, Biogen, Opus, OS Therapies, Roche, Senti, Teva, Tris.
Read More

Regulatory actions for Dec. 10, 2025

Dec. 10, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bendit Technologies, Heartbeam, Kane Biotech, Proverum, Vektor Medical.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 324 325 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing